Cargando…

A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study

SUMMARY: The OSARIDELPHI study evaluated the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain. The results provide expert-based recommendations for prevention, diagnosis, and treatment related to fracture risk. Therefore, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Arboleya, Luis, Cancio-Trujillo, Jose Manuel, Chaves, Celia, Duaso-Magaña, Enric, Mesa-Ramos, Manuel, Olmos, Jose Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447260/
https://www.ncbi.nlm.nih.gov/pubmed/37610481
http://dx.doi.org/10.1007/s11657-023-01318-7
_version_ 1785094523157741568
author Arboleya, Luis
Cancio-Trujillo, Jose Manuel
Chaves, Celia
Duaso-Magaña, Enric
Mesa-Ramos, Manuel
Olmos, Jose Manuel
author_facet Arboleya, Luis
Cancio-Trujillo, Jose Manuel
Chaves, Celia
Duaso-Magaña, Enric
Mesa-Ramos, Manuel
Olmos, Jose Manuel
author_sort Arboleya, Luis
collection PubMed
description SUMMARY: The OSARIDELPHI study evaluated the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain. The results provide expert-based recommendations for prevention, diagnosis, and treatment related to fracture risk. Therefore, the study facilitates clinical decision-making for managing this patient’s profile. PURPOSE: To evaluate the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain. METHODS: A two-round Delphi study was performed using an online survey. In round 1, panel members rated their level of agreement with assessments on a 9-point Likert scale. Item selection was based on acceptance by ≥ 66.6% of panel experts and the agreement of the scientific committee. In round 2, the same panelists evaluated non-consensus items in round 1. RESULTS: A total of 80 panelists participated in round 1; of these, 78 completed the round 2 survey. In round 1, 122 items from 4 dimensions (definition of fracture risk: 11 items, prevention and diagnosis: 38 items, choice of treatment: 24 items, and treatment-associated quality of life: 49 items) were evaluated. The consensus was reached for 90 items (73.8%). Panelists agreed that categorizing high risk, very high risk, or imminent risk determines secondary prevention actions (97.5%). Experts agreed that treatment with bone-forming drugs should be considered in case of a very high risk of fracture, and a sequential change to antiresorptive drugs should be made after 1–2 years (97.5%). Panelists also recommended corrective action plans for non-adherent patients to improve adherence (97.5%). A total of 131 items were finally accepted after round 2. CONCLUSION: This Delphi study provides expert-based recommendations on clinical decision-making for managing patients with osteoporosis at high risk of fracture. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11657-023-01318-7.
format Online
Article
Text
id pubmed-10447260
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-104472602023-08-25 A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study Arboleya, Luis Cancio-Trujillo, Jose Manuel Chaves, Celia Duaso-Magaña, Enric Mesa-Ramos, Manuel Olmos, Jose Manuel Arch Osteoporos Original Article SUMMARY: The OSARIDELPHI study evaluated the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain. The results provide expert-based recommendations for prevention, diagnosis, and treatment related to fracture risk. Therefore, the study facilitates clinical decision-making for managing this patient’s profile. PURPOSE: To evaluate the level of agreement between specialists in osteoporosis regarding the management of patients with high-risk fractures in Spain. METHODS: A two-round Delphi study was performed using an online survey. In round 1, panel members rated their level of agreement with assessments on a 9-point Likert scale. Item selection was based on acceptance by ≥ 66.6% of panel experts and the agreement of the scientific committee. In round 2, the same panelists evaluated non-consensus items in round 1. RESULTS: A total of 80 panelists participated in round 1; of these, 78 completed the round 2 survey. In round 1, 122 items from 4 dimensions (definition of fracture risk: 11 items, prevention and diagnosis: 38 items, choice of treatment: 24 items, and treatment-associated quality of life: 49 items) were evaluated. The consensus was reached for 90 items (73.8%). Panelists agreed that categorizing high risk, very high risk, or imminent risk determines secondary prevention actions (97.5%). Experts agreed that treatment with bone-forming drugs should be considered in case of a very high risk of fracture, and a sequential change to antiresorptive drugs should be made after 1–2 years (97.5%). Panelists also recommended corrective action plans for non-adherent patients to improve adherence (97.5%). A total of 131 items were finally accepted after round 2. CONCLUSION: This Delphi study provides expert-based recommendations on clinical decision-making for managing patients with osteoporosis at high risk of fracture. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11657-023-01318-7. Springer London 2023-08-23 2023 /pmc/articles/PMC10447260/ /pubmed/37610481 http://dx.doi.org/10.1007/s11657-023-01318-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Arboleya, Luis
Cancio-Trujillo, Jose Manuel
Chaves, Celia
Duaso-Magaña, Enric
Mesa-Ramos, Manuel
Olmos, Jose Manuel
A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study
title A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study
title_full A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study
title_fullStr A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study
title_full_unstemmed A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study
title_short A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study
title_sort delphi consensus on the management of spanish patients with osteoporosis at high risk of fracture: osaridelphi study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447260/
https://www.ncbi.nlm.nih.gov/pubmed/37610481
http://dx.doi.org/10.1007/s11657-023-01318-7
work_keys_str_mv AT arboleyaluis adelphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT canciotrujillojosemanuel adelphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT chavescelia adelphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT duasomaganaenric adelphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT mesaramosmanuel adelphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT olmosjosemanuel adelphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT arboleyaluis delphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT canciotrujillojosemanuel delphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT chavescelia delphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT duasomaganaenric delphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT mesaramosmanuel delphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy
AT olmosjosemanuel delphiconsensusonthemanagementofspanishpatientswithosteoporosisathighriskoffractureosaridelphistudy